Zobrazeno 1 - 10
of 92
pro vyhledávání: '"B. Smiley"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael C. Veronesi, Yeonhee Yun, Shelby B. Smiley, Harlan E. Shannon, Sudip Kumar Das, Karen E. Pollok, Michael W. Vannier, Pranav Ayyagari
Publikováno v:
Pharmaceutical Research. 38:1067-1079
Glioblastoma (GBM) is a malignant brain tumor with a poor long-term prognosis due to recurrence from highly resistant GBM cancer stem cells (CSCs), for which the current standard of treatment with temozolomide (TMZ) alone will unlikely produce a viab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85ca2d58e101d948314a660bdfd320a9
https://doi.org/10.1007/s11095-021-03050-8
https://doi.org/10.1007/s11095-021-03050-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shelby B Smiley, Hamideh Zarrinmayeh, Sudip K Das, Karen E Pollok, Michael W Vannier, Michael C Veronesi
Publikováno v:
Therapeutic delivery. 13(4)
Glioblastoma (GBM) is a deadly malignancy with a poor prognosis. An important factor contributing to GBM recurrence is high resistance of GBM cancer stem cells (GSCs). While temozolomide (TMZ), has been shown to consistently extend survival, GSCs gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d065b71e218e24ad1fca96ca2689060b
https://pubmed.ncbi.nlm.nih.gov/35615860
https://pubmed.ncbi.nlm.nih.gov/35615860
Autor:
Steven B. Smiley
Publikováno v:
Proceedings of the American Solar Energy Society National Conference ISBN: 9783031087851
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::853d0f8e93fb23a7dd9d094eb8b1b200
https://doi.org/10.1007/978-3-031-08786-8_32
https://doi.org/10.1007/978-3-031-08786-8_32
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elyse M, Talley, Charlie T, Watts, Sonia, Aboyer, Madeline G, Adamson, Harriet Ab, Akoto, Haley, Altemus, Philip J, Avella, Rebecca, Bailey, Elizabeth R, Bell, Katheryn L, Bell, Kelsey, Breneman, Jessica S, Burkhart, Logan J, Chanley, Savannah S, Cook, Mackenzie T, DesLaurier, Timothy R, Dorsey, Cassandra J, Doyle, Merris E, Egloff, Ayoola S, Fasawe, Katy K, Garcia, Nathaniel P, Graves, Tyler K, Gray, Evan M, Gustafson, Makayla J, Hall, Jaden D, Hayes, Lindsay J, Holic, Brice A, Jarvis, Piotr S, Klos, Sidney, Kritzmire, Lera, Kuzovko, Edwyna, Lainez, Shamerra, McCoy, James C, Mierendorf, Nicole A, Neri, Caley R, Neville, Kelley, Osborn, Kaitlyn, Parker, Megan E, Parks, Kylee, Peck, Robyn, Pitt, Matthew E, Platta, Brianna, Powell, Katalina, Rodriguez, Clara, Ruiz, Mariah N, Schaefer, Amanda B, Shields, Jasmine B, Smiley, Briona, Stauffer, Devan, Straub, John L, Sweeney, Kaitlyn M, Termine, Brett, Thomas, Sophia D, Toth, Taylor R, Veile, Kayla S, Walker, Paige N, Webster, Brian J, Woodard, Quentin L, Yoder, McKenzie K, Young, McKenzie L, Zeedyk, Logan N, Ziegler, Kayla L, Bieser, David P, Puthoff, Joyce, Stamm, Alysia D, Vrailas-Mortimer, Jacob D, Kagey, Julie A, Merkle
Publikováno v:
microPublication Biology
Genetic screens are used to identify genes involved in specific biological processes. An EMS mutagenesis screen in Drosophila melanogaster identified growth control phenotypes in the developing eye. One mutant line from this screen, H.3.2, was phenot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80dba67da7aa929296386c29a138c0c2
https://pubmed.ncbi.nlm.nih.gov/34278244
https://pubmed.ncbi.nlm.nih.gov/34278244
Autor:
Shelby B, Smiley, Yeonhee, Yun, Pranav, Ayyagari, Harlan E, Shannon, Karen E, Pollok, Michael W, Vannier, Sudip K, Das, Michael C, Veronesi
Publikováno v:
Pharmaceutical research. 38(6)
Glioblastoma (GBM) is a malignant brain tumor with a poor long-term prognosis due to recurrence from highly resistant GBM cancer stem cells (CSCs), for which the current standard of treatment with temozolomide (TMZ) alone will unlikely produce a viab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::12e73f3a00376c6686d8840171e4bb97
https://pubmed.ncbi.nlm.nih.gov/34100216
https://pubmed.ncbi.nlm.nih.gov/34100216
Autor:
Meghna Sitaram, Barbara Cruvinel Santiago, B. Smiley, Hwei Ru Ong, David Schiminovich, Nicole Melso
Publikováno v:
Ground-based and Airborne Instrumentation for Astronomy VIII.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7370473aaef4ef9c468f6fbe1093f476
https://doi.org/10.1117/12.2561674
https://doi.org/10.1117/12.2561674
Autor:
Pranav Ayyagari, Shelby B. Smiley, Yeonhee Yun, Michael W. Vannier, Michael C. Veronesi, Sudip Kumar Das, Karen E. Pollok, Harlan E. Shannon
Glioblastoma (GBM) is a malignant brain tumor with a poor long-term prognosis. The current median survival is approximately fifteen to twenty months with the standard of care therapy which includes surgery, radiation, and chemotherapy. An important f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5e76c41b58d002a52100c83bdf6430c
https://doi.org/10.1101/2020.11.08.373696
https://doi.org/10.1101/2020.11.08.373696